Spyre Therapeutics (SYRE) Net Income: 2015-2025
Historic Net Income for Spyre Therapeutics (SYRE) over the last 11 years, with Sep 2025 value amounting to -$11.2 million.
- Spyre Therapeutics' Net Income rose 83.80% to -$11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$149.0 million, marking a year-over-year increase of 30.68%. This contributed to the annual value of -$208.0 million for FY2024, which is 38.60% up from last year.
- Spyre Therapeutics' Net Income amounted to -$11.2 million in Q3 2025, which was up 69.54% from -$36.7 million recorded in Q2 2025.
- In the past 5 years, Spyre Therapeutics' Net Income registered a high of -$11.2 million during Q3 2025, and its lowest value of -$217.1 million during Q2 2023.
- Its 3-year average for Net Income is -$58.1 million, with a median of -$43.9 million in 2024.
- Per our database at Business Quant, Spyre Therapeutics' Net Income plummeted by 872.45% in 2023 and then skyrocketed by 83.80% in 2025.
- Spyre Therapeutics' Net Income (Quarterly) stood at -$20.4 million in 2021, then grew by 7.94% to -$18.8 million in 2022, then crashed by 235.67% to -$63.2 million in 2023, then increased by 10.90% to -$56.3 million in 2024, then skyrocketed by 83.80% to -$11.2 million in 2025.
- Its Net Income was -$11.2 million in Q3 2025, compared to -$36.7 million in Q2 2025 and -$44.8 million in Q1 2025.